Sporangimicins A–D, acylated maltose derivatives from a rare actinomycete of the genusPseudosporangium

Cytosporones Y and Z, new antifungal polyketides produced by the fungal strain Trichoderma sp. FKI-6626

Streptomyces odontomachi sp. nov., a novel actinobacterium with antimicrobial potential isolated from ants (Odontomachus simillimus Smith, 1858)

The Journal of Antibiotics Ōmura Award for Excellence is given annually to an outstanding original research article and review article selected from the previous three volumes of the journal. See winning articles from past years here.

The October 2020 special issue of The Journal of Antibiotics “Secondary Metabolites from Mushrooms” focuses on the compounds produced by mushrooms or cultured mycelia of mushrooms. We are extremely grateful to all the researchers for their diligence in contributing their work during the unprecedented time of the coronavirus pandemic. Coordinators: Profs. Timm Anke and Kazuro Shiomi.

The October 2021 special issue of The Journal of Antibiotics “Approach toward molecular targeted therapy for cancer using microbial products” focuses on microbial secondary metabolites targeting molecules or signal transduction systems related to cancer development. We would like to thank Profs. Masaya Imoto and Manabu Kawada, the coordinators of this special issue.